This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-surprise: Archive
APA (APA) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for APA (APA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
APAPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Plains All American (PAA) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Plains All American (PAA) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
PAAPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Diamondback (FANG) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Diamondback (FANG) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
FANGPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Constellation Software Inc. (CNSWF) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Constellation Software (CNSWF) delivered earnings and revenue surprises of +29.93% and +0.57%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CNSWFNegative Net Change CINTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Core Scientific, Inc. (CORZ) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Core Scientific, Inc. (CORZ) delivered earnings and revenue surprises of +42.86% and -2.28%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CORZNegative Net Change BTMPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Clearside Biomedical (CLSD) delivered earnings and revenue surprises of +50.00% and +87.07%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CLSDPositive Net Change ARCTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Skechers (SKX) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Skechers (SKX) delivered earnings and revenue surprises of +36.14% and +4.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SKXPositive Net Change BIRKPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Femasys Inc. (FEMY) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Femasys (FEMY) delivered earnings and revenue surprises of +11.11% and -48.88%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FEMYPositive Net Change GRALPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Phunware (PHUN) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Phunware (PHUN) delivered earnings and revenue surprises of -6.67% and -38.18%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PHUNPositive Net Change GTLBPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
IonQ Secures $1.6 Billion to Power Quantum Projects: Is It a Buy Now?
by Urmimala Biswas
IonQ procures $1B funding to accelerate quantum computing and networking dominance despite near-term losses.
AZNPositive Net Change NVDANegative Net Change IONQNegative Net Change RGTIPositive Net Change QBTSPositive Net Change
cloud-computing earnings-outlook earnings-report earnings-surprise tech-stocks
Compared to Estimates, Monster Beverage (MNST) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Monster Beverage (MNST) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
MNSTPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Here's What Key Metrics Tell Us About Sweetgreen (SG) Q2 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Sweetgreen (SG) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
SGNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Datadog (DDOG) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Datadog (DDOG) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
DDOGNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Citizens & Northern (CZNC) Misses Q2 Earnings Estimates
by Zacks Equity Research
Citizens & Northern (CZNC) delivered earnings and revenue surprises of -14.89% and +4.62%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CZNCPositive Net Change BAPNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Compared to Estimates, Sotera Health (SHC) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
SHCPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Docebo Inc. (DCBO) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Docebo (DCBO) delivered earnings and revenue surprises of +45.00% and +2.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DCBOPositive Net Change INTAPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Visa's Solid Q3 Momentum Meets a Puzzling Pullback: Right Time to Buy?
by Kaibalya Pravo Dey
Visa posts double-digit Q3 gains in cross-border volumes and earnings, but shares slide 5.5% amid rising costs and regulatory risks.
MAPositive Net Change VPositive Net Change AXPPositive Net Change
blockchain business-services credit-card earnings-outlook earnings-surprise finance payments
Fox Factory Holding (FOXF) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Fox Factory Holding (FOXF) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
FOXFPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Vistra (VST) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Vistra (VST) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
VSTNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for SurModics (SRDX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
SRDXPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Strawberry Fields REIT, Inc. (STRW) Q2 FFO and Revenues Beat Estimates
by Zacks Equity Research
Strawberry Fields REIT, Inc. (STRW) delivered FFO and revenue surprises of +406.67% and +0.86%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
STRWPositive Net Change NKSHNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Hudson Global (HSON) Q2 Earnings Miss Estimates
by Zacks Equity Research
Hudson Global (HSON) delivered earnings and revenue surprises of -29.41% and +3.38%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HSONPositive Net Change IBTAPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
fuboTV (FUBO) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for fuboTV (FUBO) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
FUBOPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Tempus (TEM) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Tempus (TEM) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
TEMPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Heron Therapeutics (HRTX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Heron Therapeutics (HRTX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
HRTXPositive Net Change
earnings earnings-estimates-revisions earnings-surprise